6
Total investments
1
Early stage
2
Mid stage
3
Late stage
6y
Years active
Portfolio
6 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2026
Animab is a new venture designed to address the changing needs of animal production. Using proprietary research discoveries, Animab targets the emerging science and new possibilities in the gut. The interdisciplinary team integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies and sustainability. Led by an experienced group of experts with expertise in a range of relevant domains from vaccines, biotechnology, business management and international marketing, Animab is dedicated to offering a safe and sustainable way to ensure animal performance. More information: www.animab.com.
Board Member
Nov 2023
As fast-spreading viral diseases are a constant threat to the livestock industry, ViroVet’s team of researchers and unique network of academic and industrial partners will deliver products to reduce the impact of these diseases by providing innovative virus control solutions to secure and improve the health and value of livestock.
Board Member
Aug 2021
Introducing Morrow Eyewear: Revolutionizing Vision with Cutting-Edge Liquid Crystal Technology
At Morrow Eyewear, we're pushing the boundaries of vision enhancement by integrating state-of-the-art liquid crystal technology into our premium eyewear products. Our innovative lenses are designed to deliver unparalleled comfort, adaptability, and performance to those who demand the best from their eyewear.
Our dynamic liquid crystal lenses empower users to experience a seamless transition between varying distances, ensuring optimal vision and a stylish look in every situation. With Morrow Eyewear, you'll enjoy crystal-clear vision and remarkable convenience, all wrapped in a sleek and modern design.
Welcome to the future of eyewear – Experience the Morrow difference today.
Board Observer
Mar 2021
Protealis is an innovative company fostering the cultivation of sustainable plant-based proteins in Europe. We develop superior seeds and seed technologies for legume crops that are adapted to our local environment. By combining innovation in breeding and nitrogen fixation we create new opportunities for European farmers to help overcome Europe’s protein deficit and provide local sourcing options for the growing number of producers of meat and milk alternatives.
Board Observer
Apr 2020
We are a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of effective and safe products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are on track to launch our first biofungicide in the USA in H2 2022, followed by subsequent market introductions globally. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
A
Board Member
Apr 2020
Aphea.Bio is dedicated to food security and ensuring a safe and healthy food chain. We aim to provide novel, science-based solutions to build the agriculture of the future: sustainable, reliable and profitable.
Located in Gent, Belgium, we have a highly dedicated and qualified team of scientist and industry experts. Based on our unique high throughput R&D platform utilizing the untapped microbial space, we have been able to build a broad pipeline based on naturally occurring micro-organisms.
Our solutions range from biostimulants to biocontrol, and focus mainly on row crops.
Our key strength is flexibility, which allows us to quickly adapt to market needs and to provide tailored solutions.
We believe that with a fresh and sincere spirit of innovation, result-driven science, and the courage to go off the beaten track, there is fertile ground to develop efficacious biological solutions to help complement or partially replace products in the major chemical indications.
Experience · 8 entries
All (8)
Investments (6)
Board (6)
2026
Board Member
Apr 2026
Animab is a new venture designed to address the changing needs of animal production. Using proprietary research discoveries, Animab targets the emerging science and new possibilities in the gut. The interdisciplinary team integrates cutting-edge research, animal science, and biotechnology for product breakthroughs in animal health, cost-efficiencies and sustainability. Led by an experienced group of experts with expertise in a range of relevant domains from vaccines, biotechnology, business management and international marketing, Animab is dedicated to offering a safe and sustainable way to ensure animal performance. More information: www.animab.com.
2023
Board Member
Nov 2023
As fast-spreading viral diseases are a constant threat to the livestock industry, ViroVet’s team of researchers and unique network of academic and industrial partners will deliver products to reduce the impact of these diseases by providing innovative virus control solutions to secure and improve the health and value of livestock.
2021
Board Member
Aug 2021
Introducing Morrow Eyewear: Revolutionizing Vision with Cutting-Edge Liquid Crystal Technology
At Morrow Eyewear, we're pushing the boundaries of vision enhancement by integrating state-of-the-art liquid crystal technology into our premium eyewear products. Our innovative lenses are designed to deliver unparalleled comfort, adaptability, and performance to those who demand the best from their eyewear.
Our dynamic liquid crystal lenses empower users to experience a seamless transition between varying distances, ensuring optimal vision and a stylish look in every situation. With Morrow Eyewear, you'll enjoy crystal-clear vision and remarkable convenience, all wrapped in a sleek and modern design.
Welcome to the future of eyewear – Experience the Morrow difference today.
Board Observer
Mar 2021
Protealis is an innovative company fostering the cultivation of sustainable plant-based proteins in Europe. We develop superior seeds and seed technologies for legume crops that are adapted to our local environment. By combining innovation in breeding and nitrogen fixation we create new opportunities for European farmers to help overcome Europe’s protein deficit and provide local sourcing options for the growing number of producers of meat and milk alternatives.
2020
Board Observer
Apr 2020
We are a rapidly growing and transformative food and crop protection company developing a new generation of protein-based biocontrol solutions, shaping the future of sustainable and safe food supply. Based on our ground-breaking technology platform, Biotalys is developing a broad pipeline of effective and safe products with novel modes of action, addressing key crop pests and diseases across the whole value chain, from soil to plate. Biotalys’ unique protein-based biocontrols combine the high-performance characteristics of chemicals with the clean safety profile of biologicals, making them ideal crop protection agents for both pre- and post-harvest applications. We are on track to launch our first biofungicide in the USA in H2 2022, followed by subsequent market introductions globally. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.
Show all 8 entries ↓
Investment activity
2020–2026 · 6 investments
Recent (last 2 years)Earlier
